-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Upgrades Nuveen Churchill Direct to Buy, Lowers Price Target to $13

Benzinga·09/01/2026 13:02:30
Listen to the news
UBS analyst Melissa Wedel upgrades Nuveen Churchill Direct (NYSE:NCDL) from Neutral to Buy and lowers the price target from $14.75 to $13.